Novartis halted drug development while Northwell Health continues research on related projects.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novartis halted drug development while Northwell Health continues research on related projects.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Novartis
Swiss-American multinational pharmaceutical corporation
-
Northwell Health
private nonprofit healthcare network in Long Island, New York, United States
Nothing else this week.
Related events
- Novartis is headquartered in Basel, Switzerland.
- Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.
- Novartis is offering potential support to the national health fund in Ghana, which provides equipment and support to the Komfo Anokye Teaching Hospital.
- Novartis operated through a wholly owned subsidiary in India on July 1, 2026.
- Novartis is shifting its R&D focus to India, moving operations outside of Switzerland.
Coverage
Newest first; wire copies grouped- rutlandherald.comNorthwell Scientist Reveals Breakthrough Results in Eye Cancer Drug